— Know what they know.
Not Investment Advice

PCVX NASDAQ

Vaxcyte, Inc.
1W: -11.5% 1M: -22.1% 3M: -19.0% YTD: +2.0% 1Y: +29.6% 3Y: -1.8% 5Y: +146.3%
$47.30
-0.09 (-0.19%)
 
Weekly Expected Move ±6.5%
$46 $49 $52 $56 $59
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 29 · $6.8B mcap · 132M float · 1.07% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.0 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -63.6%  ·  5Y Avg: 18.8%
Cost Advantage
33
Intangibles
25
Switching Cost
43
Network Effect
47
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PCVX has No discernible competitive edge (34.0/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -63.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$89
Avg Target
$89
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$89.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-25 BTIG Tom Shrader $160 $89 -71 +41.2% $63.04
2025-11-19 Leerink Partners David Risinger $135 $77 -58 +55.5% $49.53
2024-11-06 Jefferies Roger Song $129 $146 +17 +36.8% $106.73
2024-11-06 Leerink Partners David Risinger $153 $135 -18 +26.5% $106.73
2024-09-10 Mizuho Securities Salim Syed $113 $163 +50 +41.4% $115.28
2024-09-04 Bank of America Securities Jason Gerberry Initiated $140 +27.1% $110.15
2024-09-03 Leerink Partners David Risinger $60 $153 +93 +36.6% $112.04
2024-09-03 BTIG Tom Shrader $98 $160 +62 +45.3% $110.15
2024-09-03 Jefferies Roger Song Initiated $129 +16.1% $111.12
2024-09-03 Mizuho Securities Salim Syed Initiated $113 +1.7% $111.08
2024-08-07 BTIG Tom Shrader $69 $98 +29 +39.0% $70.52
2023-01-03 Needham Initiated $58 +21.0% $47.95
2022-12-16 Leerink Partners Initiated $60 +31.9% $45.48
2022-12-15 Guggenheim Initiated $66 +44.4% $45.72
2022-11-17 BTIG Initiated $69 +59.2% $43.35

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PCVX receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 C C-
2026-05-04 C- C
2026-04-01 C C-
2026-02-26 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
84
Earnings Quality
59
Growth
Value
38
Momentum
Safety
100
Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
12.01
Safe Zone
Piotroski F-Score
1/9
Beneish M-Score
Ohlson O-Score
-5.07
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Stable
Earnings Quality
OCF/NI: 0.81x
Accruals: -5.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PCVX scores 12.01, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PCVX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PCVX's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PCVX receives an estimated rating of A+ (score: 75.6/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.97x
PEG
0.15x
P/S
0.00x
P/B
2.20x
P/FCF
-10.51x
P/OCF
EV/EBITDA
-7.16x
EV/Revenue
EV/EBIT
-6.97x
EV/FCF
-8.78x
Earnings Yield
-11.68%
FCF Yield
-9.52%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PCVX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.974
EBT / EBIT
×
EBIT Margin
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.094
Assets / Equity
=
ROE
-31.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PCVX's ROE of -31.6% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1494 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$47.30
Median 1Y
$42.11
5th Pctile
$14.02
95th Pctile
$129.05
Ann. Volatility
66.0%
Analyst Target
$89.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
507
+22.5% YoY
Revenue / Employee
Profit / Employee
$-1,512,087
NI: $-766,628,000
SGA / Employee
$255,166
Avg labor cost proxy
R&D / Employee
$1,566,679
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -72.4% -77.0% -31.8% -37.4% -45.3% -55.2% -36.1% -39.6% -42.8% -48.4% -36.7% -39.8% -45.3% -46.3% -20.4% -22.4% -24.1% -28.9% -25.6% -31.6% -31.60%
ROA -37.8% -40.2% -27.9% -32.9% -39.8% -48.5% -33.6% -36.8% -39.8% -45.0% -33.3% -36.2% -41.2% -42.1% -18.9% -20.7% -22.3% -26.7% -23.4% -28.9% -28.87%
ROIC 1.7% 1.8% -1.5% -1.7% -2.1% -2.5% -4.6% -5.2% -6.0% -7.0% -2.0% -2.1% -2.4% -2.5% -27.6% -30.8% -34.4% -39.3% -53.9% -63.6% -63.55%
ROCE -25.6% -27.2% -34.5% -39.9% -48.3% -58.9% -23.2% -26.4% -30.2% -35.7% -35.4% -38.9% -44.3% -46.6% -13.8% -15.7% -16.1% -18.3% -28.4% -34.2% -34.21%
Gross Margin
Operating Margin
Net Margin
EBITDA Margin
FCF Margin
OCF Margin
ROE 3Y Avg snapshot only -28.63%
ROE 5Y Avg snapshot only -30.61%
ROA 3Y Avg snapshot only -25.54%
ROIC Economic snapshot only -29.51%
Cash ROA snapshot only -25.28%
Cash ROIC snapshot only -56.89%
CROIC snapshot only -57.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -13.38 -14.35 -13.01 -11.79 -9.27 -8.55 -16.21 -13.19 -18.50 -17.30 -16.30 -17.47 -17.81 -27.84 -21.68 -10.05 -8.08 -7.46 -8.19 -8.56 -6.971
P/S Ratio 0.000
P/B Ratio 3.35 3.83 4.58 4.89 4.66 5.24 3.80 3.39 5.14 5.44 5.29 6.15 7.14 11.39 3.04 1.55 1.34 1.48 2.34 3.02 2.202
P/FCF -16.58 -15.22 -10.18 -9.64 -8.63 -9.15 -20.53 -16.23 -22.29 -21.14 -17.98 -15.81 -15.04 -22.70 -17.39 -8.54 -8.27 -8.29 -9.38 -10.51 -10.505
P/OCF
EV/EBITDA -8.94 -10.24 -10.89 -10.31 -8.04 -7.58 -12.64 -9.43 -14.14 -12.74 -12.59 -13.69 -14.25 -22.80 -18.68 -6.72 -5.23 -5.38 -6.33 -7.16 -7.162
EV/Revenue
EV/EBIT -8.73 -9.96 -10.52 -9.84 -7.66 -7.23 -12.12 -9.09 -13.68 -12.39 -12.31 -13.39 -13.94 -22.26 -18.04 -6.50 -5.05 -5.23 -6.13 -6.97 -6.971
EV/FCF -11.06 -10.78 -8.39 -8.05 -7.14 -7.74 -15.35 -11.64 -18.14 -17.42 -15.10 -13.63 -13.25 -21.01 -14.49 -5.75 -5.13 -5.46 -7.39 -8.78 -8.779
Earnings Yield -7.5% -7.0% -7.7% -8.5% -10.8% -11.7% -6.2% -7.6% -5.4% -5.8% -6.1% -5.7% -5.6% -3.6% -4.6% -9.9% -12.4% -13.4% -12.2% -11.7% -11.68%
FCF Yield -6.0% -6.6% -9.8% -10.4% -11.6% -10.9% -4.9% -6.2% -4.5% -4.7% -5.6% -6.3% -6.6% -4.4% -5.7% -11.7% -12.1% -12.1% -10.7% -9.5% -9.52%
PEG Ratio snapshot only 0.150
Price/Tangible Book snapshot only 3.019
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 8.30 8.30 8.93 8.93 8.93 8.93 23.26 23.26 23.26 23.26 7.54 7.54 7.54 7.54 12.75 12.75 12.75 12.75 7.91 7.91 7.909
Quick Ratio 8.30 8.30 8.93 8.93 8.93 8.93 23.26 23.26 23.26 23.26 7.54 7.54 7.54 7.54 12.75 12.75 12.75 12.75 7.91 7.91 7.909
Debt/Equity 0.00 0.00 0.06 0.06 0.06 0.06 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.09 0.09 0.085
Net Debt/Equity -1.12 -1.12 -0.81 -0.81 -0.81 -0.81 -0.96 -0.96 -0.96 -0.96 -0.85 -0.85 -0.85 -0.85 -0.51 -0.51 -0.51 -0.51 -0.50 -0.50 -0.496
Debt/Assets 0.00 0.00 0.05 0.05 0.05 0.05 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.08 0.08 0.075
Debt/EBITDA -0.00 -0.00 -0.17 -0.15 -0.12 -0.10 -0.08 -0.07 -0.06 -0.05 -0.07 -0.06 -0.05 -0.05 -0.16 -0.14 -0.14 -0.12 -0.29 -0.24 -0.242
Net Debt/EBITDA 4.46 4.22 2.33 2.04 1.68 1.38 4.26 3.72 3.24 2.73 2.40 2.19 1.92 1.83 3.74 3.27 3.19 2.79 1.70 1.41 1.408
Interest Coverage -12652.86 -13452.43 -14570.43 -16844.43 -71384.50 -87035.50 -111779.00 -127517.50
Equity Multiplier 1.14 1.14 1.14 1.14 1.14 1.14 1.06 1.06 1.06 1.06 1.13 1.13 1.13 1.13 1.06 1.06 1.06 1.06 1.13 1.13 1.134
Cash Ratio snapshot only 7.587
Cash to Debt snapshot only 6.821
FCF to Debt snapshot only -3.372
Defensive Interval snapshot only 541.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.16 0.00 0.10 0.098
DSO
DIO 0 0 0 0.0 days
DPO 2306 2306 3721 3721.0 days
Cash Conversion Cycle
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue
Net Income -3.3% -1.2% -61.2% -41.5% -64.7% -88.6% -1.2% -1.1% -85.5% -72.1% -80.0% -78.3% -87.8% -69.5% -15.3% -16.7% -10.1% -29.5% -65.2% -85.7% -85.73%
EPS -3.0% -1.2% -50.1% -25.8% -39.5% -58.8% -61.8% -38.8% -15.1% -5.0% -30.2% -37.6% -57.0% -39.3% 2.0% 4.0% 5.1% -17.6% -49.2% -80.7% -80.65%
FCF -6.6% -2.9% -2.8% -2.0% -1.2% -86.9% -37.9% -38.2% -43.3% -50.8% -1.1% -1.4% -1.7% -1.5% -58.6% -24.3% 9.1% 5.0% -15.8% -28.6% -28.61%
EBITDA -3.3% -1.3% -61.4% -34.6% -57.4% -81.2% -1.2% -1.2% -1.1% -1.0% -1.0% -95.4% -94.3% -71.2% -2.6% -6.8% 4.1% -4.5% -74.3% -84.3% -84.34%
Op. Income -3.1% -1.2% -67.3% -40.7% -64.2% -88.2% -1.2% -1.2% -1.1% -1.0% -1.0% -93.5% -90.2% -68.8% -21.7% -24.4% -22.9% -34.4% -62.2% -71.2% -71.22%
OCF Growth snapshot only -67.46%
Asset Growth snapshot only -13.25%
Equity Growth snapshot only -18.76%
Debt Growth snapshot only 2.22%
Shares Change snapshot only 2.81%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 1.5% 1.5% 53.0% 53.0% 53.0% 53.0% 1.2% 1.2% 1.2% 1.2% 44.7% 44.7% 44.66%
Assets 5Y 1.2% 1.2% 50.6% 50.6% 50.63%
Equity 3Y 53.1% 53.1% 53.1% 53.1% 1.3% 1.3% 1.3% 1.3% 41.2% 41.2% 41.22%
Book Value 3Y 20.5% 18.0% 16.4% 14.8% 73.1% 70.3% 73.3% 74.3% 16.1% 20.3% 20.28%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earnings Stability 1.00 0.98 0.91 0.90 0.97 0.96 0.93 0.92 0.91 0.93 0.96 0.96 0.95 0.95 0.94 0.90 0.895
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.94 0.93 0.96 0.88 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.03 0.07 0.10 0.13 -0.03 -0.02 -0.01 0.05 0.14 0.15 0.17 0.16 -0.05 -0.10 -0.099
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.76 0.88 1.21 1.15 1.03 0.90 0.76 0.78 0.81 0.78 0.74 0.93 0.94 0.93 0.98 0.90 0.84 0.82 0.86 0.81 0.813
FCF/OCF 1.06 1.07 1.05 1.06 1.05 1.04 1.03 1.04 1.03 1.05 1.23 1.18 1.26 1.32 1.28 1.31 1.16 1.09 1.02 1.00 1.002
FCF/Net Income snapshot only 0.815
CapEx/Revenue
CapEx/Depreciation snapshot only 0.068
Accruals Ratio -0.09 -0.05 0.06 0.05 0.01 -0.05 -0.08 -0.08 -0.08 -0.10 -0.09 -0.02 -0.03 -0.03 -0.00 -0.02 -0.04 -0.05 -0.03 -0.05 -0.054
Sloan Accruals snapshot only -0.077
Cash Flow Adequacy snapshot only -438.456
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -0.5% -1.1% -9.0% -13.1% -14.1% -23.6% -24.4% -26.2% -24.9% -9.7% -18.5% -11.0% -17.2% -24.2% -31.6% -34.3% -0.1% 0.0% -7.5% -7.54%
Total Shareholder Return 0.0% -0.5% -1.1% -9.0% -13.1% -14.1% -23.6% -24.4% -26.2% -24.9% -9.7% -18.5% -11.0% -17.2% -24.2% -31.6% -34.3% -0.1% 0.0% -7.5% -7.54%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 0.98 0.98 1.00 1.00 1.00 1.00 0.96 0.91 0.87 0.90 0.89 0.89 0.86 1.00 0.96 1.01 1.06 0.95 0.97 0.974
EBIT Margin
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.91 1.91 1.14 1.14 1.14 1.14 1.08 1.08 1.08 1.08 1.10 1.10 1.10 1.10 1.08 1.08 1.08 1.08 1.09 1.09 1.094
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.68 $-1.77 $-1.83 $-2.05 $-2.35 $-2.81 $-2.96 $-2.84 $-2.70 $-2.95 $-3.85 $-3.91 $-4.24 $-4.10 $-3.78 $-3.76 $-4.02 $-4.83 $-5.63 $-6.78 $-6.78
Book Value/Share $6.71 $6.63 $5.19 $4.94 $4.67 $4.58 $12.62 $11.06 $9.73 $9.38 $11.88 $11.11 $10.58 $10.03 $26.91 $24.36 $24.30 $24.27 $19.73 $19.25 $21.48
Tangible Book/Share $6.71 $6.63 $5.19 $4.94 $4.67 $4.58 $12.62 $11.06 $9.73 $9.38 $11.88 $11.11 $10.58 $10.03 $26.91 $24.36 $24.30 $24.27 $19.73 $19.25 $19.25
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.36 $-1.67 $-2.34 $-2.50 $-2.52 $-2.62 $-2.34 $-2.31 $-2.24 $-2.41 $-3.49 $-4.32 $-5.02 $-5.03 $-4.71 $-4.42 $-3.93 $-4.34 $-4.92 $-5.53 $-5.53
OCF/Share $-1.28 $-1.55 $-2.22 $-2.36 $-2.41 $-2.52 $-2.26 $-2.21 $-2.18 $-2.29 $-2.84 $-3.65 $-3.98 $-3.80 $-3.68 $-3.39 $-3.38 $-3.98 $-4.82 $-5.52 $-5.52
Cash/Share $7.50 $7.40 $4.49 $4.27 $4.04 $3.97 $12.33 $10.80 $9.50 $9.16 $10.34 $9.67 $9.21 $8.73 $14.22 $12.88 $12.84 $12.83 $11.47 $11.19 $12.45
EBITDA/Share $-1.68 $-1.75 $-1.80 $-1.96 $-2.24 $-2.68 $-2.84 $-2.85 $-2.87 $-3.30 $-4.19 $-4.30 $-4.67 $-4.64 $-3.65 $-3.78 $-3.86 $-4.40 $-5.75 $-6.78 $-6.78
Debt/Share $0.00 $0.00 $0.31 $0.29 $0.28 $0.27 $0.24 $0.21 $0.18 $0.18 $0.28 $0.26 $0.25 $0.24 $0.58 $0.52 $0.52 $0.52 $1.68 $1.64 $1.64
Net Debt/Share $-7.50 $-7.40 $-4.19 $-3.98 $-3.77 $-3.70 $-12.09 $-10.60 $-9.32 $-8.98 $-10.06 $-9.41 $-8.96 $-8.50 $-13.64 $-12.35 $-12.32 $-12.31 $-9.79 $-9.55 $-9.55
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 12.011
Altman Z-Prime snapshot only 22.226
Piotroski F-Score 2 3 1 1 1 2 3 3 4 4 2 2 2 2 4 4 4 4 1 1 1
Beneish M-Score
Ohlson O-Score snapshot only -5.065
ROIC (Greenblatt) snapshot only -50.79%
Net-Net WC snapshot only $9.08
EVA snapshot only $-995437180.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 67.88 67.63 61.06 61.83 63.30 63.72 65.60 65.10 76.41 76.48 76.71 76.44 76.56 76.30 76.29 76.25 76.42 76.04 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only -0.641
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms